These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14259464)

  • 1. INFLUENCE OF DIETARY PROTEIN ON COMPLEMENT, PROPERDIN, AND HEMOLYSIN IN ADULT PROTEIN-DEPLETED RATS.
    Kenney MA; Arnrich L; Mar E; Roderuck CE
    J Nutr; 1965 Feb; 85(2):213-20. PubMed ID: 14259464
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. IV. RELATION OF SERUM COMPLEMENT ACTIVITY AND PROPERDIN LEVEL OF NORMAL ALBINO RATS TO STREPTOMYCIN THERAPY AND DIET.
    SEN R; MATHUR PD; MAJUMDAR AC
    Ann Biochem Exp Med; 1963 Dec; 23():577-82. PubMed ID: 14154202
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial properdin deficiency.
    Davis CA; Forristal J
    J Lab Clin Med; 1980 Oct; 96(4):633-9. PubMed ID: 6903190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NATURAL IMMUNITY.
    HOWARD JG
    Mod Trends Immunol; 1963; 1():86-106. PubMed ID: 14138642
    [No Abstract]   [Full Text] [Related]  

  • 5. CHANGES OF SERUM COMPLEMENT AND PROPERDIN LEVELS IN EXPERIMENTAL TYPHOID FEVER. A LONGITUDINAL STUDY OF THE DISEASE INCLUDING THE INCUBATION PERIOD AND THE PHASE OF RECOVERY FOLLOWING TREATMENT WITH CHLORAMPHENICOL.
    SCHUBART AF; HORNICK RB; EWALD RW; SCHROEDER WC; MYERBURG RJ; GOODMAN JS; WOODWARD TE
    J Immunol; 1964 Sep; 93():387-96. PubMed ID: 14218595
    [No Abstract]   [Full Text] [Related]  

  • 6. HUMORAL FACTORS IN CELLULAR RESISTANCE. II. THE ROLE OF COMPLEMENT AND PROPERDIN IN PHAGOCYTOSIS AND CYTOPEPSIS BY NORMAL AND "IMMUNE" MACROPHAGES.
    WU WG; MARCUS S
    J Immunol; 1964 Mar; 92():397-403. PubMed ID: 14128985
    [No Abstract]   [Full Text] [Related]  

  • 7. [NATURAL INNATE IMMUNITY FOR BRUCELLA MELITENSIS. I. RELATION WITH PROPERDIN, COMPLEMENT, BACTERICIDAL PROPERTIES OF SERUM AND THE FORMATION OF SPECIFIC ANTIBODIES].
    LEON AP; OSOLLO G; CANO C
    Rev Inst Salubr Enferm Trop; 1962 Dec; 22():145-72. PubMed ID: 14076958
    [No Abstract]   [Full Text] [Related]  

  • 8. [IMMUNE FACTORS IN EXPERIMENTAL POISONING BY AMYL, BUTYL, AND PROPYL ACETATES. II: BEHAVIOR OF COMPLEMENT CAPACITY, HEMOLYTIC CAPACITY AND OF NATURAL HEMOLYSINS].
    INSERRA A; ELEFANTE E; SFOGLIANO C
    Folia Med (Napoli); 1964 Nov; 47():1130-8. PubMed ID: 14277336
    [No Abstract]   [Full Text] [Related]  

  • 9. HEMOLYTIC COMPLEMENT AND SERUM BACTERICIDIN.
    KOPPER PH
    Nature; 1963 Dec; 200():1332. PubMed ID: 14098492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observations on the level of properdin, complement and its fractions after splenectomy].
    Jasser S; Bragiel I; Kwietniak K
    Pol Tyg Lek; 1965 Aug; 20(32):1193-5. PubMed ID: 5846629
    [No Abstract]   [Full Text] [Related]  

  • 11. INHIBITION OF COMPLEMENT BY CARRAGEENIN: MODE OF ACTION, EFFECT ON ALLERGIC REACTIONS AND ON COMPLEMENT OF VARIOUS SPECIES.
    DAVIES GE
    Immunology; 1965 Mar; 8(3):291-9. PubMed ID: 14315111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of plant extracts on the complement & properdin system].
    BUSING KH; THURIGEN G
    Allerg Asthma (Leipz); 1958; 4(1):30-3. PubMed ID: 13582813
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement activation by tubular cells is mediated by properdin binding.
    Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biological significance of the complement-properdin system].
    PFANNENSTIEL W
    Hippokrates; 1960 Jun; 31():389-95. PubMed ID: 14432510
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    Götze O; Medicus RG; Müller-Eberhard HJ
    J Immunol; 1977 Feb; 118(2):525-32. PubMed ID: 839069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathological variations of complement and properdin in man].
    SOULIER JP; MENACHE D
    Acta Haematol; 1958; 20(1-4):260-74. PubMed ID: 13582572
    [No Abstract]   [Full Text] [Related]  

  • 17. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER
    Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
    [No Abstract]   [Full Text] [Related]  

  • 18. [HYPOTHESES FOR THE OCCURRENCE OF A CYTOLYZING EFFECT CAUSED BY PHOSPHATIDASE A].
    KELLER R
    Helv Physiol Pharmacol Acta; 1964; 22():C76-8. PubMed ID: 14223900
    [No Abstract]   [Full Text] [Related]  

  • 19. CHARACTERIZATION OF A GENETICALLY IDENTIFIABLE COMPONENT OF COMPLEMENT IN MICE.
    TACHIBANA DK; ROSENBERG LT
    Folia Microbiol (Praha); 1964 May; 14():129-44. PubMed ID: 14181467
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):339-48. PubMed ID: 13539378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.